A Viability Analysis of Tumor-Bearing Frozen Autograft for the Reconstruction After Resection of Malignant Bone Tumors Using 99mTc-MDP Scintigraphy. (14th January 2023)
- Record Type:
- Journal Article
- Title:
- A Viability Analysis of Tumor-Bearing Frozen Autograft for the Reconstruction After Resection of Malignant Bone Tumors Using 99mTc-MDP Scintigraphy. (14th January 2023)
- Main Title:
- A Viability Analysis of Tumor-Bearing Frozen Autograft for the Reconstruction After Resection of Malignant Bone Tumors Using 99mTc-MDP Scintigraphy
- Authors:
- Araki, Yoshihiro
Yamamoto, Norio
Hayashi, Katsuhiro
Takeuchi, Akihiko
Miwa, Shinji
Igarashi, Kentaro
Higuchi, Takashi
Abe, Kensaku
Taniguchi, Yuta
Yonezawa, Hirotaka
Morinaga, Sei
Asano, Yohei
Nojima, Takayuki
Taki, Junichi
Tsuchiya, Hiroyuki - Abstract:
- Abstract : Purpose of the Report: Several methods are used to reconstruct bony defects after malignant tumor excision. Tumor-bearing frozen autograft reconstruction is a biological procedure in which tumor-bearing bone is reused after devitalization with liquid nitrogen to kill tumor cells. The viability of frozen autografts has not been fully evaluated over time. We therefore aimed to evaluate the viability of devitalized bone grafts, using 99m Tc-MDP scintigraphy. Patients and Methods: Seventy-four patients who underwent frozen autograft reconstruction after the excision of a malignant bone tumor were enrolled. Two hundred forty-two postoperative 99m Tc-MDP scans were reviewed. For a quantitative analysis, the region of interest on the frozen bone segment and a symmetric region of interest on the contralateral normal area were manually set. The radioactive tracer uptake ratio was calculated by dividing the count density of the frozen bone segment by that of the contralateral normal area in each image. An uptake ratio of 0.9 to 1.1 was defined as a normalization of tracer uptake. Results: Normalization of tracer uptake was achieved in 95% to 97% of the cases by 60 months postoperatively, and earlier in the middle zone and peripheral zone in the pedicle freezing group in comparison to the free freezing group (both P = 0.03). Fracture and nonunion was associated with a low uptake ratio, whereas infection was associated with a high uptake ratio before the occurrence of theAbstract : Purpose of the Report: Several methods are used to reconstruct bony defects after malignant tumor excision. Tumor-bearing frozen autograft reconstruction is a biological procedure in which tumor-bearing bone is reused after devitalization with liquid nitrogen to kill tumor cells. The viability of frozen autografts has not been fully evaluated over time. We therefore aimed to evaluate the viability of devitalized bone grafts, using 99m Tc-MDP scintigraphy. Patients and Methods: Seventy-four patients who underwent frozen autograft reconstruction after the excision of a malignant bone tumor were enrolled. Two hundred forty-two postoperative 99m Tc-MDP scans were reviewed. For a quantitative analysis, the region of interest on the frozen bone segment and a symmetric region of interest on the contralateral normal area were manually set. The radioactive tracer uptake ratio was calculated by dividing the count density of the frozen bone segment by that of the contralateral normal area in each image. An uptake ratio of 0.9 to 1.1 was defined as a normalization of tracer uptake. Results: Normalization of tracer uptake was achieved in 95% to 97% of the cases by 60 months postoperatively, and earlier in the middle zone and peripheral zone in the pedicle freezing group in comparison to the free freezing group (both P = 0.03). Fracture and nonunion was associated with a low uptake ratio, whereas infection was associated with a high uptake ratio before the occurrence of the event. Conclusions: The calculation of the uptake ratio using 99m Tc-MDP scans was an objective and accurate evaluation method. The period to normalization of tracer uptake in the pedicle frozen bone was significantly earlier than that in the free frozen bone. The postoperative complications can be also predicted. … (more)
- Is Part Of:
- Clinical nuclear medicine. Volume 48:Number 1(2023)
- Journal:
- Clinical nuclear medicine
- Issue:
- Volume 48:Number 1(2023)
- Issue Display:
- Volume 48, Issue 1 (2023)
- Year:
- 2023
- Volume:
- 48
- Issue:
- 1
- Issue Sort Value:
- 2023-0048-0001-0000
- Page Start:
- 25
- Page End:
- 34
- Publication Date:
- 2023-01-14
- Subjects:
- viability -- frozen autograft -- over time -- 99mTc-MDP
Nuclear medicine -- Periodicals
Radioisotope scanning -- Periodicals
Nuclear Medicine -- Periodicals
616.07575 - Journal URLs:
- http://gateway.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&NEWS=n&PAGE=toc&D=ovft&AN=00003072-000000000-00000 ↗
http://journals.lww.com/nuclearmed/pages/default.aspx ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/RLU.0000000000004436 ↗
- Languages:
- English
- ISSNs:
- 0363-9762
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.314000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 24612.xml